Y. N. Abdiche, Y. A. Yeung, J. Chaparro-riggers, I. Barman, P. Strop et al., The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity, mAbs, vol.7, pp.331-343, 2015.

M. E. Ackerman, M. Crispin, X. Yu, K. Baruah, A. W. Boesch et al., Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity, J. Clin. Invest, vol.123, pp.2183-2192, 2013.

K. J. Bar, M. C. Sneller, L. J. Harrison, J. S. Justement, E. T. Overton et al., Effect of HIV antibody VRC01 on viral rebound after treatment interruption, N. Engl. J. Med, vol.375, pp.2037-2050, 2016.

A. Bertolotti-ciarlet, W. Wang, R. Lownes, P. Pristatsky, Y. Fang et al., Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptors, Mol. Immunol, vol.46, pp.1878-1882, 2009.

G. R. Bolton, M. E. Ackerman, and A. W. Boesch, Separation of nonfucosylated antibodies with immobilized FcgammaRIII receptors, Biotechnol. Prog, vol.29, pp.825-828, 2013.

D. Bosch, A. Castilho, A. Loos, A. Schots, and H. Steinkellner, NGlycosylation of plant-produced recombinant proteins, Curr. Pharm. Design, vol.19, pp.5503-5512, 2013.

S. Bournazos, F. Klein, J. Pietzsch, M. S. Seaman, M. C. Nussenzweig et al., Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity, Cell, vol.158, pp.1243-1253, 2014.

W. P. Burmeister, A. H. Huber, and P. J. Bjorkman, Crystal structure of the complex of rat neonatal Fc receptor with Fc, Nature, vol.372, pp.379-383, 1994.

M. Caskey, F. Klein, J. C. Lorenzi, M. S. Seaman, A. P. West et al., Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117, Nature, vol.522, pp.487-491, 2015.

A. Castilho, C. Gruber, A. Thader, C. Oostenbrink, M. Pechlaner et al., Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation, MAbs, vol.7, pp.863-870, 2015.

A. Castilho, G. Beihammer, C. Pfeiffer, K. Goritzer, L. Montero-morales et al., An oligosaccharyltransferase from Leishmania major increases the N-glycan occupancy on recombinant glycoproteins produced in Nicotiana benthamiana, Plant Biotechnol. J, vol.16, pp.1700-1709, 2018.

, The Authors, Plant Biotechnology Journal published by Society for Experimental Biology and The Association of Applied Biologists, pp.1-13, 2019.

, Antibody engineering for Fc receptor binding 11

D. Chargelegue, P. M. Drake, P. Obregon, A. Prada, N. Fairweather et al., Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants, Infect. Immun, vol.73, pp.5915-5922, 2005.

T. W. Chun, D. Murray, J. S. Justement, J. Blazkova, C. W. Hallahan et al., Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir, Proc. Natl Acad. Sci. USA, vol.111, pp.13151-13156, 2014.

A. W. Chung, M. Ghebremichael, H. Robinson, E. Brown, I. Choi et al., Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines, Sci. Transl. Med, vol.6, pp.228-238, 2014.

K. M. Cox, J. D. Sterling, J. T. Regan, J. R. Gasdaska, K. K. Frantz et al., Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor, Nat. Biotechnol, vol.24, pp.1591-1597, 2006.

T. A. Crowell, D. J. Colby, S. Pinyakorn, C. Sacdalan, A. Pagliuzza et al., Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial, Lancet HIV, vol.6, pp.297-306, 2019.

W. F. Dall'acqua, R. M. Woods, E. S. Ward, S. R. Palaszynski, N. K. Patel et al., Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences, J. Immunol, vol.169, pp.5171-5180, 2002.

J. R. Desjarlais and G. A. Lazar, Modulation of antibody effector function, Exp. Cell Res, vol.317, pp.1278-1285, 2011.

D. M. Ecker, S. D. Jones, and H. L. Levine, The therapeutic monoclonal antibody market, MAbs, vol.7, pp.9-14, 2015.

C. Ferrara, S. Grau, C. Jager, P. Sondermann, P. Brunker et al., Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose, Proc. Natl Acad. Sci. USA, vol.108, pp.12669-12674, 2011.

D. N. Forthal, J. S. Gach, G. Landucci, J. Jez, R. Strasser et al., Fc-glycosylation influences Fcgamma receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12, J. Immunol, vol.185, pp.6876-6882, 2010.

A. Frostell, Towards an optimized in-vitro SPR assay for antibody Fc gamma receptor binding kinetics, GE Healthcare Life Sciences, 2015.

X. Gao, J. A. Ji, K. Veeravalli, Y. J. Wang, T. Zhang et al., Effect of individual Fc methionine oxidation on FcRn binding: Met252 oxidation impairs FcRn binding more profoundly than Met428 oxidation, J. Pharm. Sci, vol.104, pp.368-377, 2015.

R. Gautam, Y. Nishimura, A. Pegu, M. C. Nason, F. Klein et al., A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges, Nature, vol.533, pp.105-109, 2016.

S. W. Griffiths and C. L. Cooney, Relationship between protein structure and methionine oxidation in recombinant human alpha 1-antitrypsin, Biochemistry, vol.41, pp.6245-6252, 2002.

M. Guilliams, P. Bruhns, Y. Saeys, H. Hammad, and B. N. Lambrecht, The function of Fcgamma receptors in dendritic cells and macrophages, Nat. Rev. Immunol, vol.14, pp.94-108, 2014.

J. M. Hayes, A. Frostell, E. F. Cosgrave, W. B. Struwe, O. Potter et al., Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions, J. Proteome Res, vol.13, pp.5471-5485, 2014.

V. K. Hehle, M. J. Paul, P. M. Drake, J. K. Ma, C. J. Van-dolleweerd et al., Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond, Nat. Rev. Drug Discov, vol.11, pp.311-331, 2011.

R. F. Hurrell, P. A. Finot, and J. L. Cuq, Protein-polyphenol reactions. 1. Nutritional and metabolic consequences of the reaction between oxidized caffeic acid and the lysine residues of casein, Brit. J. Nutr, vol.47, pp.191-211, 1982.

V. Irani, A. J. Guy, D. Andrew, J. G. Beeson, P. A. Ramsland et al., Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases, 2015.

, Mol. Immunol, vol.67, pp.171-182

R. Jefferis, Glycosylation as a strategy to improve antibody-based therapeutics, Nat. Rev. Drug Discovery, vol.8, pp.226-234, 2009.

R. Jefferis, Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action, Trends Pharmacol. Sci, vol.30, pp.356-362, 2009.

R. Jefferis, Isotype and glycoform selection for antibody therapeutics, Arch. Biochem. Biophys, vol.526, pp.159-166, 2012.

J. Jez, B. Antes, A. Castilho, M. Kainer, S. Wiederkum et al., Significant impact of single N-glycan residues on the biological activity of Fc-based antibody-like fragments, J. Biol. Chem, vol.287, pp.24313-24319, 2012.

R. P. Junghans and C. L. Anderson, The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor, Proc. Natl Acad. Sci. USA, vol.93, pp.5512-5516, 1996.

T. T. Junttila, K. Parsons, C. Olsson, Y. Lu, Y. Xin et al., Superior in vivo efficacy of afucosylated trastuzumab in the treatment of HER2-amplified breast cancer, Cancer Res, vol.70, pp.4481-4489, 2010.

J. Kapila, R. Derycke, M. Vanmontagu, and G. Angenon, An Agrobacterium-mediated transient gene expression system for intact leaves, Plant Sci, vol.122, pp.101-108, 1997.

H. Khoudi, S. Laberge, J. M. Ferullo, R. Bazin, A. Darveau et al., Production of a diagnostic monoclonal antibody in perennial alfalfa plants, Biotechnol. Bioeng, vol.64, pp.135-143, 1999.

K. Ko, Y. Tekoah, P. M. Rudd, D. J. Harvey, R. A. Dwek et al., Function and glycosylation of plant-derived antiviral monoclonal antibody, Proc. Natl Acad. Sci. USA, vol.100, pp.8013-8018, 2003.

S. Y. Ko, A. Pegu, R. S. Rudicell, Z. Y. Yang, M. G. Joyce et al., Enhanced neonatal Fc receptor function improves protection against primate SHIV infection, Nature, vol.514, pp.642-645, 2014.

J. E. Ledgerwood, E. E. Coates, G. Yamshchikov, J. G. Saunders, L. Holman et al., Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults, Clin. Exp. Immunol, vol.182, pp.289-301, 2015.

J. H. Lee, D. Y. Park, K. J. Lee, Y. K. Kim, Y. K. So et al., Intracellular reprogramming of expression, glycosylation, and function of a plant-derived antiviral therapeutic monoclonal antibody, PLoS ONE, vol.8, p.68772, 2013.

S. Li, C. Schoneich, and R. T. Borchardt, Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization, Biotechnol. Bioeng, vol.48, pp.490-500, 1995.

Z. Li, L. Wang, G. Yang, H. Shi, C. Jiang et al., Study on the determination of polyphenols in tobacco by HPLC coupled with ESI-MS after solid-phase extraction, J. Chromatogr. Sci, vol.41, pp.36-40, 2003.

A. Loos and H. Steinkellner, IgG-Fc glycoengineering in non-mammalian expression hosts, Arch. Biochem. Biophys, vol.526, pp.167-173, 2012.

J. K. Ma, P. Christou, R. Chikwamba, H. Haydon, M. Paul et al., Realising the value of plant molecular pharming to benefit the poor in developing countries and emerging economies, Plant Biotechnol. J, vol.11, pp.1029-1033, 2013.

J. K. Ma, J. Drossard, D. Lewis, F. Altmann, J. Boyle et al., Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants, Plant Biotechnol. J, vol.13, pp.1106-1120, 2015.

L. M. Madeira, T. H. Szeto, J. K. Ma, and P. M. Drake, Rhizosecretion improves the production of Cyanovirin-N in Nicotiana tabacum through simplified downstream processing, Biotechnol. J, vol.11, pp.910-919, 2016.

M. C. Manning, D. K. Chou, B. M. Murphy, R. W. Payne, and D. S. Katayama, Stability of protein pharmaceuticals: an update, Pharm. Res, vol.27, pp.544-575, 2010.

W. L. Martin, A. P. West, . Jr, L. Gan, and P. J. Bjorkman, Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding, Mol. Cell, vol.7, pp.867-877, 2001.

P. Mendoza, H. Gruell, L. Nogueira, J. A. Pai, A. L. Butler et al., Combination therapy with anti-HIV-1 antibodies maintains viral suppression, Nature, vol.561, pp.479-484, 2018.

S. Miletic, D. J. Simpson, C. M. Szymanski, M. K. Deyholos, and R. Menassa, A plant-produced bacteriophage tailspike protein for the control of salmonella. Front. Plant Sci. 6, 1221. ª 2019 The Authors, Plant Biotechnology Journal published by Society for Experimental Biology and The Association of Applied Biologists, pp.1-13, 2015.

L. Montero-morales and H. Steinkellner, Advanced plant-based glycan engineering, Front. Bioeng. Biotechnol, vol.6, p.81, 2018.

R. Nezlin and V. Ghetie, Interactions of immunoglobulins outside the antigen-combining site, Adv. Immunol, vol.82, pp.155-215, 2004.

F. Nimmerjahn and J. V. Ravetch, Fcgamma receptors as regulators of immune responses, Nat. Rev. Immunol, vol.8, pp.34-47, 2008.

V. Oganesyan, M. M. Damschroder, K. E. Cook, Q. Li, C. Gao et al., Structural insights into neonatal Fc receptor-based recycling mechanisms, J. Biol. Chem, vol.289, pp.7812-7824, 2014.

J. M. Osborne, G. W. Chacko, J. T. Brandt, and C. L. Anderson, Ethnic variation in frequency of an allelic polymorphism of human Fc gamma RIIA determined with allele specific oligonucleotide probes, J. Immunol. Methods, vol.173, pp.207-217, 1994.

H. Pan, K. Chen, L. Chu, F. Kinderman, I. Apostol et al., Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn, Protein Sci, vol.18, pp.424-433, 2009.

M. J. Paul, A. Y. Teh, R. M. Twyman, and J. K. Ma, Target product selection -where can Molecular Pharming make the difference?, Curr. Pharm. Des, vol.19, pp.5478-5485, 2013.

N. W. Pirie, Leaf protein -beneficiary of tribulation, Nature, vol.253, pp.239-241, 1975.

R. Piron, F. Santens, A. De-paepe, A. Depicker, and N. Callewaert, Using GlycoDelete to produce proteins lacking plant-specific N-glycan modification in seeds, Nat. Biotechnol, vol.33, pp.1135-1137, 2015.

J. Ravetch, In vivo veritas: the surprising roles of Fc receptors in immunity, Nat. Immunol, vol.11, pp.183-185, 2010.

J. V. Ravetch and B. Perussia, Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions, J. Exp. Med, vol.170, pp.481-497, 1989.

S. A. Riddler, L. Zheng, C. M. Durand, J. Ritz, R. A. Koup et al., Randomized clinical trial to assess the impact of the broadly neutralizing HIV-1 monoclonal antibody VRC01 on HIV-1 persistence in individuals on effective ART, Open Forum Infect. Dis, vol.5, p.242, 2018.

Y. Rosenberg, M. Sack, D. Montefiori, D. Forthal, L. Mao et al., Rapid high-level production of functional HIV broadly neutralizing monoclonal antibodies in transient plant expression systems, PLoS ONE, vol.8, p.58724, 2013.

Y. Rosenberg, M. Sack, D. Montefiori, C. Labranche, M. Lewis et al., Pharmacokinetics and immunogenicity of broadly neutralizing HIV monoclonal antibodies in macaques, PLoS ONE, vol.10, p.120451, 2015.

F. Sainsbury, E. C. Thuenemann, and G. P. Lomonossoff, pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants, Plant Biotechnol. J, vol.7, pp.682-693, 2009.

J. Schneider, A. Castilho, M. Pabst, F. Altmann, C. Gruber et al., Characterization of plants expressing the human beta1,4-galactosyltrasferase gene, Plant Physiol. Biochem, vol.92, pp.39-47, 2015.

M. Schuster, W. Jost, G. C. Mudde, S. Wiederkum, C. Schwager et al., In vivo glyco-engineered antibody with improved lytic potential produced by an innovative non-mammalian expression system, Biotechnol. J, vol.2, pp.700-708, 2007.

R. L. Shields, J. Lai, R. Keck, L. Y. O'connell, K. Hong et al., Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity, J. Biol. Chem, vol.277, pp.26733-26740, 2002.

J. Stadlmann, M. Pabst, D. Kolarich, R. Kunert, and F. Altmann, Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides, Proteomics, vol.8, pp.2858-2871, 2008.

R. Strasser, J. Stadlmann, M. Schahs, G. Stiegler, H. Quendler et al., Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure, Plant Biotechnol. J, vol.6, pp.392-402, 2008.

R. Strasser, A. Castilho, J. Stadlmann, R. Kunert, H. Quendler et al., Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile, J. Biol. Chem, vol.284, pp.20479-20485, 2009.

R. L. Synge, Interactions of polyphenols with proteins in plants and plant products, Qual. Plant, vol.24, pp.337-350, 1975.

A. Y. Teh, D. Maresch, K. Klein, and J. K. Ma, Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco, Plant Biotechnol. J, vol.12, pp.300-311, 2014.

D. B. Tesar, N. E. Tiangco, and P. J. Bjorkman, Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor, Traffic, vol.7, pp.1127-1142, 2006.

M. Thomann, T. Schlothauer, T. Dashivets, S. Malik, C. Avenal et al., vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity, vol.10, p.134949, 2015.

A. Triguero, G. Cabrera, M. Rodriguez, J. Soto, Y. Zamora et al., Differential N-glycosylation of a monoclonal antibody expressed in tobacco leaves with and without endoplasmic reticulum retention signal apparently induces similar in vivo stability in mice, Plant Biotechnol. J, vol.9, pp.1120-1130, 2011.

S. Tsuchiya, M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno et al., Establishment and characterization of a human acute monocytic leukemia cell line (THP-1), Int. J. Cancer, vol.26, pp.171-176, 1980.

G. Vanier, F. Hempel, P. Chan, M. Rodamer, D. Vaudry et al., Biochemical characterization of human anti-hepatitis B monoclonal antibody produced in the microalgae phaeodactylum tricornutum, PLoS ONE, vol.10, p.139282, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01841078

D. E. Vaughn and P. J. Bjorkman, Structural basis of pH-dependent antibody binding by the neonatal Fc receptor, Structure, vol.6, pp.63-73, 1998.

E. S. Ward, S. C. Devanaboyina, and R. J. Ober, Targeting FcRn for the modulation of antibody dynamics, Mol. Immunol, vol.67, pp.131-141, 2015.

P. A. Warmerdam, J. G. Van-de-winkel, E. J. Gosselin, and P. J. Capel, Molecular basis for a polymorphism of human Fc gamma receptor II (CD32), 1990.

, J. Exp. Med, vol.172, pp.19-25

X. Wu, Z. Y. Yang, Y. Li, C. M. Hogerkorp, W. R. Schief et al., Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1, Science, vol.329, pp.856-861, 2010.

J. Zalevsky, A. K. Chamberlain, H. M. Horton, S. Karki, I. W. Leung et al., Enhanced antibody half-life improves in vivo activity, Nat. Biotechnol, vol.28, pp.157-159, 2010.

L. Zeitlin, J. Pettitt, C. Scully, N. Bohorova, D. Kim et al., Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant, Proc. Natl Acad. Sci. USA, vol.108, pp.20690-20694, 2011.